Medical Care
Global Mesenchymal Stem Cell (MSC) Therapy Market Research Report 2025
- May 12, 25
- ID: 235597
- Pages: 86
- Figures: 89
- Views: 11
The global market for Mesenchymal Stem Cell (MSC) Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Mesenchymal Stem Cells (MSCs), also known as mesenchymal stromal cells, are multipotent cells that can differentiate into a variety of cell types, including osteocytes, chondrocytes, myocytes, and adipocytes (the fat that gives rise to bone marrow adipose tissue cells) and have the ability to self-renew.
North American market for Mesenchymal Stem Cell (MSC) Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Mesenchymal Stem Cell (MSC) Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Mesenchymal Stem Cell (MSC) Therapy in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Mesenchymal Stem Cell (MSC) Therapy include TotiCell, Celltex, InGeneron, Stempeutics Bangalore, PuREC, Corestem, Sartorius, StemcellX, Cynata, Amniotic, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Mesenchymal Stem Cell (MSC) Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesenchymal Stem Cell (MSC) Therapy.
The Mesenchymal Stem Cell (MSC) Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mesenchymal Stem Cell (MSC) Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesenchymal Stem Cell (MSC) Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
TotiCell
Celltex
InGeneron
Stempeutics Bangalore
PuREC
Corestem
Sartorius
StemcellX
Cynata
Amniotic
Nuwacell
Segment by Type
Intravenous (IV)
Intranasal (IN)
Intraarticular (IA)
Others
Segment by Application
Hospital
Clinic
Research Institute
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mesenchymal Stem Cell (MSC) Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Mesenchymal Stem Cells (MSCs), also known as mesenchymal stromal cells, are multipotent cells that can differentiate into a variety of cell types, including osteocytes, chondrocytes, myocytes, and adipocytes (the fat that gives rise to bone marrow adipose tissue cells) and have the ability to self-renew.
North American market for Mesenchymal Stem Cell (MSC) Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Mesenchymal Stem Cell (MSC) Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Mesenchymal Stem Cell (MSC) Therapy in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Mesenchymal Stem Cell (MSC) Therapy include TotiCell, Celltex, InGeneron, Stempeutics Bangalore, PuREC, Corestem, Sartorius, StemcellX, Cynata, Amniotic, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Mesenchymal Stem Cell (MSC) Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesenchymal Stem Cell (MSC) Therapy.
The Mesenchymal Stem Cell (MSC) Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mesenchymal Stem Cell (MSC) Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesenchymal Stem Cell (MSC) Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
TotiCell
Celltex
InGeneron
Stempeutics Bangalore
PuREC
Corestem
Sartorius
StemcellX
Cynata
Amniotic
Nuwacell
Segment by Type
Intravenous (IV)
Intranasal (IN)
Intraarticular (IA)
Others
Segment by Application
Hospital
Clinic
Research Institute
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mesenchymal Stem Cell (MSC) Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mesenchymal Stem Cell (MSC) Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Intravenous (IV)
1.2.3 Intranasal (IN)
1.2.4 Intraarticular (IA)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Mesenchymal Stem Cell (MSC) Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mesenchymal Stem Cell (MSC) Therapy Market Perspective (2020-2031)
2.2 Global Mesenchymal Stem Cell (MSC) Therapy Growth Trends by Region
2.2.1 Global Mesenchymal Stem Cell (MSC) Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Mesenchymal Stem Cell (MSC) Therapy Historic Market Size by Region (2020-2025)
2.2.3 Mesenchymal Stem Cell (MSC) Therapy Forecasted Market Size by Region (2026-2031)
2.3 Mesenchymal Stem Cell (MSC) Therapy Market Dynamics
2.3.1 Mesenchymal Stem Cell (MSC) Therapy Industry Trends
2.3.2 Mesenchymal Stem Cell (MSC) Therapy Market Drivers
2.3.3 Mesenchymal Stem Cell (MSC) Therapy Market Challenges
2.3.4 Mesenchymal Stem Cell (MSC) Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mesenchymal Stem Cell (MSC) Therapy Players by Revenue
3.1.1 Global Top Mesenchymal Stem Cell (MSC) Therapy Players by Revenue (2020-2025)
3.1.2 Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Mesenchymal Stem Cell (MSC) Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Mesenchymal Stem Cell (MSC) Therapy Revenue
3.4 Global Mesenchymal Stem Cell (MSC) Therapy Market Concentration Ratio
3.4.1 Global Mesenchymal Stem Cell (MSC) Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mesenchymal Stem Cell (MSC) Therapy Revenue in 2024
3.5 Global Key Players of Mesenchymal Stem Cell (MSC) Therapy Head office and Area Served
3.6 Global Key Players of Mesenchymal Stem Cell (MSC) Therapy, Product and Application
3.7 Global Key Players of Mesenchymal Stem Cell (MSC) Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mesenchymal Stem Cell (MSC) Therapy Breakdown Data by Type
4.1 Global Mesenchymal Stem Cell (MSC) Therapy Historic Market Size by Type (2020-2025)
4.2 Global Mesenchymal Stem Cell (MSC) Therapy Forecasted Market Size by Type (2026-2031)
5 Mesenchymal Stem Cell (MSC) Therapy Breakdown Data by Application
5.1 Global Mesenchymal Stem Cell (MSC) Therapy Historic Market Size by Application (2020-2025)
5.2 Global Mesenchymal Stem Cell (MSC) Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Mesenchymal Stem Cell (MSC) Therapy Market Size (2020-2031)
6.2 North America Mesenchymal Stem Cell (MSC) Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2020-2025)
6.4 North America Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mesenchymal Stem Cell (MSC) Therapy Market Size (2020-2031)
7.2 Europe Mesenchymal Stem Cell (MSC) Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2020-2025)
7.4 Europe Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mesenchymal Stem Cell (MSC) Therapy Market Size (2020-2031)
8.2 Asia-Pacific Mesenchymal Stem Cell (MSC) Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Mesenchymal Stem Cell (MSC) Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Mesenchymal Stem Cell (MSC) Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mesenchymal Stem Cell (MSC) Therapy Market Size (2020-2031)
9.2 Latin America Mesenchymal Stem Cell (MSC) Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2020-2025)
9.4 Latin America Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Market Size (2020-2031)
10.2 Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 TotiCell
11.1.1 TotiCell Company Details
11.1.2 TotiCell Business Overview
11.1.3 TotiCell Mesenchymal Stem Cell (MSC) Therapy Introduction
11.1.4 TotiCell Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.1.5 TotiCell Recent Development
11.2 Celltex
11.2.1 Celltex Company Details
11.2.2 Celltex Business Overview
11.2.3 Celltex Mesenchymal Stem Cell (MSC) Therapy Introduction
11.2.4 Celltex Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.2.5 Celltex Recent Development
11.3 InGeneron
11.3.1 InGeneron Company Details
11.3.2 InGeneron Business Overview
11.3.3 InGeneron Mesenchymal Stem Cell (MSC) Therapy Introduction
11.3.4 InGeneron Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.3.5 InGeneron Recent Development
11.4 Stempeutics Bangalore
11.4.1 Stempeutics Bangalore Company Details
11.4.2 Stempeutics Bangalore Business Overview
11.4.3 Stempeutics Bangalore Mesenchymal Stem Cell (MSC) Therapy Introduction
11.4.4 Stempeutics Bangalore Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.4.5 Stempeutics Bangalore Recent Development
11.5 PuREC
11.5.1 PuREC Company Details
11.5.2 PuREC Business Overview
11.5.3 PuREC Mesenchymal Stem Cell (MSC) Therapy Introduction
11.5.4 PuREC Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.5.5 PuREC Recent Development
11.6 Corestem
11.6.1 Corestem Company Details
11.6.2 Corestem Business Overview
11.6.3 Corestem Mesenchymal Stem Cell (MSC) Therapy Introduction
11.6.4 Corestem Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.6.5 Corestem Recent Development
11.7 Sartorius
11.7.1 Sartorius Company Details
11.7.2 Sartorius Business Overview
11.7.3 Sartorius Mesenchymal Stem Cell (MSC) Therapy Introduction
11.7.4 Sartorius Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.7.5 Sartorius Recent Development
11.8 StemcellX
11.8.1 StemcellX Company Details
11.8.2 StemcellX Business Overview
11.8.3 StemcellX Mesenchymal Stem Cell (MSC) Therapy Introduction
11.8.4 StemcellX Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.8.5 StemcellX Recent Development
11.9 Cynata
11.9.1 Cynata Company Details
11.9.2 Cynata Business Overview
11.9.3 Cynata Mesenchymal Stem Cell (MSC) Therapy Introduction
11.9.4 Cynata Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.9.5 Cynata Recent Development
11.10 Amniotic
11.10.1 Amniotic Company Details
11.10.2 Amniotic Business Overview
11.10.3 Amniotic Mesenchymal Stem Cell (MSC) Therapy Introduction
11.10.4 Amniotic Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.10.5 Amniotic Recent Development
11.11 Nuwacell
11.11.1 Nuwacell Company Details
11.11.2 Nuwacell Business Overview
11.11.3 Nuwacell Mesenchymal Stem Cell (MSC) Therapy Introduction
11.11.4 Nuwacell Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.11.5 Nuwacell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mesenchymal Stem Cell (MSC) Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Intravenous (IV)
1.2.3 Intranasal (IN)
1.2.4 Intraarticular (IA)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Mesenchymal Stem Cell (MSC) Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mesenchymal Stem Cell (MSC) Therapy Market Perspective (2020-2031)
2.2 Global Mesenchymal Stem Cell (MSC) Therapy Growth Trends by Region
2.2.1 Global Mesenchymal Stem Cell (MSC) Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Mesenchymal Stem Cell (MSC) Therapy Historic Market Size by Region (2020-2025)
2.2.3 Mesenchymal Stem Cell (MSC) Therapy Forecasted Market Size by Region (2026-2031)
2.3 Mesenchymal Stem Cell (MSC) Therapy Market Dynamics
2.3.1 Mesenchymal Stem Cell (MSC) Therapy Industry Trends
2.3.2 Mesenchymal Stem Cell (MSC) Therapy Market Drivers
2.3.3 Mesenchymal Stem Cell (MSC) Therapy Market Challenges
2.3.4 Mesenchymal Stem Cell (MSC) Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mesenchymal Stem Cell (MSC) Therapy Players by Revenue
3.1.1 Global Top Mesenchymal Stem Cell (MSC) Therapy Players by Revenue (2020-2025)
3.1.2 Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Mesenchymal Stem Cell (MSC) Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Mesenchymal Stem Cell (MSC) Therapy Revenue
3.4 Global Mesenchymal Stem Cell (MSC) Therapy Market Concentration Ratio
3.4.1 Global Mesenchymal Stem Cell (MSC) Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mesenchymal Stem Cell (MSC) Therapy Revenue in 2024
3.5 Global Key Players of Mesenchymal Stem Cell (MSC) Therapy Head office and Area Served
3.6 Global Key Players of Mesenchymal Stem Cell (MSC) Therapy, Product and Application
3.7 Global Key Players of Mesenchymal Stem Cell (MSC) Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mesenchymal Stem Cell (MSC) Therapy Breakdown Data by Type
4.1 Global Mesenchymal Stem Cell (MSC) Therapy Historic Market Size by Type (2020-2025)
4.2 Global Mesenchymal Stem Cell (MSC) Therapy Forecasted Market Size by Type (2026-2031)
5 Mesenchymal Stem Cell (MSC) Therapy Breakdown Data by Application
5.1 Global Mesenchymal Stem Cell (MSC) Therapy Historic Market Size by Application (2020-2025)
5.2 Global Mesenchymal Stem Cell (MSC) Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Mesenchymal Stem Cell (MSC) Therapy Market Size (2020-2031)
6.2 North America Mesenchymal Stem Cell (MSC) Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2020-2025)
6.4 North America Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mesenchymal Stem Cell (MSC) Therapy Market Size (2020-2031)
7.2 Europe Mesenchymal Stem Cell (MSC) Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2020-2025)
7.4 Europe Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mesenchymal Stem Cell (MSC) Therapy Market Size (2020-2031)
8.2 Asia-Pacific Mesenchymal Stem Cell (MSC) Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Mesenchymal Stem Cell (MSC) Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Mesenchymal Stem Cell (MSC) Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mesenchymal Stem Cell (MSC) Therapy Market Size (2020-2031)
9.2 Latin America Mesenchymal Stem Cell (MSC) Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2020-2025)
9.4 Latin America Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Market Size (2020-2031)
10.2 Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 TotiCell
11.1.1 TotiCell Company Details
11.1.2 TotiCell Business Overview
11.1.3 TotiCell Mesenchymal Stem Cell (MSC) Therapy Introduction
11.1.4 TotiCell Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.1.5 TotiCell Recent Development
11.2 Celltex
11.2.1 Celltex Company Details
11.2.2 Celltex Business Overview
11.2.3 Celltex Mesenchymal Stem Cell (MSC) Therapy Introduction
11.2.4 Celltex Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.2.5 Celltex Recent Development
11.3 InGeneron
11.3.1 InGeneron Company Details
11.3.2 InGeneron Business Overview
11.3.3 InGeneron Mesenchymal Stem Cell (MSC) Therapy Introduction
11.3.4 InGeneron Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.3.5 InGeneron Recent Development
11.4 Stempeutics Bangalore
11.4.1 Stempeutics Bangalore Company Details
11.4.2 Stempeutics Bangalore Business Overview
11.4.3 Stempeutics Bangalore Mesenchymal Stem Cell (MSC) Therapy Introduction
11.4.4 Stempeutics Bangalore Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.4.5 Stempeutics Bangalore Recent Development
11.5 PuREC
11.5.1 PuREC Company Details
11.5.2 PuREC Business Overview
11.5.3 PuREC Mesenchymal Stem Cell (MSC) Therapy Introduction
11.5.4 PuREC Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.5.5 PuREC Recent Development
11.6 Corestem
11.6.1 Corestem Company Details
11.6.2 Corestem Business Overview
11.6.3 Corestem Mesenchymal Stem Cell (MSC) Therapy Introduction
11.6.4 Corestem Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.6.5 Corestem Recent Development
11.7 Sartorius
11.7.1 Sartorius Company Details
11.7.2 Sartorius Business Overview
11.7.3 Sartorius Mesenchymal Stem Cell (MSC) Therapy Introduction
11.7.4 Sartorius Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.7.5 Sartorius Recent Development
11.8 StemcellX
11.8.1 StemcellX Company Details
11.8.2 StemcellX Business Overview
11.8.3 StemcellX Mesenchymal Stem Cell (MSC) Therapy Introduction
11.8.4 StemcellX Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.8.5 StemcellX Recent Development
11.9 Cynata
11.9.1 Cynata Company Details
11.9.2 Cynata Business Overview
11.9.3 Cynata Mesenchymal Stem Cell (MSC) Therapy Introduction
11.9.4 Cynata Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.9.5 Cynata Recent Development
11.10 Amniotic
11.10.1 Amniotic Company Details
11.10.2 Amniotic Business Overview
11.10.3 Amniotic Mesenchymal Stem Cell (MSC) Therapy Introduction
11.10.4 Amniotic Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.10.5 Amniotic Recent Development
11.11 Nuwacell
11.11.1 Nuwacell Company Details
11.11.2 Nuwacell Business Overview
11.11.3 Nuwacell Mesenchymal Stem Cell (MSC) Therapy Introduction
11.11.4 Nuwacell Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
11.11.5 Nuwacell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Mesenchymal Stem Cell (MSC) Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Intravenous (IV)
Table 3. Key Players of Intranasal (IN)
Table 4. Key Players of Intraarticular (IA)
Table 5. Key Players of Others
Table 6. Global Mesenchymal Stem Cell (MSC) Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Mesenchymal Stem Cell (MSC) Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Mesenchymal Stem Cell (MSC) Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Mesenchymal Stem Cell (MSC) Therapy Market Share by Region (2020-2025)
Table 10. Global Mesenchymal Stem Cell (MSC) Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Mesenchymal Stem Cell (MSC) Therapy Market Share by Region (2026-2031)
Table 12. Mesenchymal Stem Cell (MSC) Therapy Market Trends
Table 13. Mesenchymal Stem Cell (MSC) Therapy Market Drivers
Table 14. Mesenchymal Stem Cell (MSC) Therapy Market Challenges
Table 15. Mesenchymal Stem Cell (MSC) Therapy Market Restraints
Table 16. Global Mesenchymal Stem Cell (MSC) Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Mesenchymal Stem Cell (MSC) Therapy Market Share by Players (2020-2025)
Table 18. Global Top Mesenchymal Stem Cell (MSC) Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesenchymal Stem Cell (MSC) Therapy as of 2024)
Table 19. Ranking of Global Top Mesenchymal Stem Cell (MSC) Therapy Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Mesenchymal Stem Cell (MSC) Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Mesenchymal Stem Cell (MSC) Therapy, Headquarters and Area Served
Table 22. Global Key Players of Mesenchymal Stem Cell (MSC) Therapy, Product and Application
Table 23. Global Key Players of Mesenchymal Stem Cell (MSC) Therapy, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Mesenchymal Stem Cell (MSC) Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share by Type (2020-2025)
Table 27. Global Mesenchymal Stem Cell (MSC) Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share by Type (2026-2031)
Table 29. Global Mesenchymal Stem Cell (MSC) Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share by Application (2020-2025)
Table 31. Global Mesenchymal Stem Cell (MSC) Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share by Application (2026-2031)
Table 33. North America Mesenchymal Stem Cell (MSC) Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Mesenchymal Stem Cell (MSC) Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Mesenchymal Stem Cell (MSC) Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Mesenchymal Stem Cell (MSC) Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Mesenchymal Stem Cell (MSC) Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Mesenchymal Stem Cell (MSC) Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 48. TotiCell Company Details
Table 49. TotiCell Business Overview
Table 50. TotiCell Mesenchymal Stem Cell (MSC) Therapy Product
Table 51. TotiCell Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 52. TotiCell Recent Development
Table 53. Celltex Company Details
Table 54. Celltex Business Overview
Table 55. Celltex Mesenchymal Stem Cell (MSC) Therapy Product
Table 56. Celltex Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 57. Celltex Recent Development
Table 58. InGeneron Company Details
Table 59. InGeneron Business Overview
Table 60. InGeneron Mesenchymal Stem Cell (MSC) Therapy Product
Table 61. InGeneron Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 62. InGeneron Recent Development
Table 63. Stempeutics Bangalore Company Details
Table 64. Stempeutics Bangalore Business Overview
Table 65. Stempeutics Bangalore Mesenchymal Stem Cell (MSC) Therapy Product
Table 66. Stempeutics Bangalore Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 67. Stempeutics Bangalore Recent Development
Table 68. PuREC Company Details
Table 69. PuREC Business Overview
Table 70. PuREC Mesenchymal Stem Cell (MSC) Therapy Product
Table 71. PuREC Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 72. PuREC Recent Development
Table 73. Corestem Company Details
Table 74. Corestem Business Overview
Table 75. Corestem Mesenchymal Stem Cell (MSC) Therapy Product
Table 76. Corestem Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 77. Corestem Recent Development
Table 78. Sartorius Company Details
Table 79. Sartorius Business Overview
Table 80. Sartorius Mesenchymal Stem Cell (MSC) Therapy Product
Table 81. Sartorius Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 82. Sartorius Recent Development
Table 83. StemcellX Company Details
Table 84. StemcellX Business Overview
Table 85. StemcellX Mesenchymal Stem Cell (MSC) Therapy Product
Table 86. StemcellX Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 87. StemcellX Recent Development
Table 88. Cynata Company Details
Table 89. Cynata Business Overview
Table 90. Cynata Mesenchymal Stem Cell (MSC) Therapy Product
Table 91. Cynata Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 92. Cynata Recent Development
Table 93. Amniotic Company Details
Table 94. Amniotic Business Overview
Table 95. Amniotic Mesenchymal Stem Cell (MSC) Therapy Product
Table 96. Amniotic Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 97. Amniotic Recent Development
Table 98. Nuwacell Company Details
Table 99. Nuwacell Business Overview
Table 100. Nuwacell Mesenchymal Stem Cell (MSC) Therapy Product
Table 101. Nuwacell Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 102. Nuwacell Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Mesenchymal Stem Cell (MSC) Therapy Picture
Figure 2. Global Mesenchymal Stem Cell (MSC) Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Mesenchymal Stem Cell (MSC) Therapy Market Share by Type: 2024 VS 2031
Figure 4. Intravenous (IV) Features
Figure 5. Intranasal (IN) Features
Figure 6. Intraarticular (IA) Features
Figure 7. Others Features
Figure 8. Global Mesenchymal Stem Cell (MSC) Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Mesenchymal Stem Cell (MSC) Therapy Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Research Institute Case Studies
Figure 13. Others Case Studies
Figure 14. Mesenchymal Stem Cell (MSC) Therapy Report Years Considered
Figure 15. Global Mesenchymal Stem Cell (MSC) Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Mesenchymal Stem Cell (MSC) Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Mesenchymal Stem Cell (MSC) Therapy Market Share by Region: 2024 VS 2031
Figure 18. Global Mesenchymal Stem Cell (MSC) Therapy Market Share by Players in 2024
Figure 19. Global Top Mesenchymal Stem Cell (MSC) Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesenchymal Stem Cell (MSC) Therapy as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Mesenchymal Stem Cell (MSC) Therapy Revenue in 2024
Figure 21. North America Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Mesenchymal Stem Cell (MSC) Therapy Market Share by Country (2020-2031)
Figure 23. United States Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Mesenchymal Stem Cell (MSC) Therapy Market Share by Country (2020-2031)
Figure 27. Germany Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Mesenchymal Stem Cell (MSC) Therapy Market Share by Region (2020-2031)
Figure 35. China Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Mesenchymal Stem Cell (MSC) Therapy Market Share by Country (2020-2031)
Figure 43. Mexico Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Market Share by Country (2020-2031)
Figure 47. Turkey Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. TotiCell Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 51. Celltex Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 52. InGeneron Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 53. Stempeutics Bangalore Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 54. PuREC Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 55. Corestem Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 56. Sartorius Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 57. StemcellX Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 58. Cynata Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 59. Amniotic Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 60. Nuwacell Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Mesenchymal Stem Cell (MSC) Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Intravenous (IV)
Table 3. Key Players of Intranasal (IN)
Table 4. Key Players of Intraarticular (IA)
Table 5. Key Players of Others
Table 6. Global Mesenchymal Stem Cell (MSC) Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Mesenchymal Stem Cell (MSC) Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Mesenchymal Stem Cell (MSC) Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Mesenchymal Stem Cell (MSC) Therapy Market Share by Region (2020-2025)
Table 10. Global Mesenchymal Stem Cell (MSC) Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Mesenchymal Stem Cell (MSC) Therapy Market Share by Region (2026-2031)
Table 12. Mesenchymal Stem Cell (MSC) Therapy Market Trends
Table 13. Mesenchymal Stem Cell (MSC) Therapy Market Drivers
Table 14. Mesenchymal Stem Cell (MSC) Therapy Market Challenges
Table 15. Mesenchymal Stem Cell (MSC) Therapy Market Restraints
Table 16. Global Mesenchymal Stem Cell (MSC) Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Mesenchymal Stem Cell (MSC) Therapy Market Share by Players (2020-2025)
Table 18. Global Top Mesenchymal Stem Cell (MSC) Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesenchymal Stem Cell (MSC) Therapy as of 2024)
Table 19. Ranking of Global Top Mesenchymal Stem Cell (MSC) Therapy Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Mesenchymal Stem Cell (MSC) Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Mesenchymal Stem Cell (MSC) Therapy, Headquarters and Area Served
Table 22. Global Key Players of Mesenchymal Stem Cell (MSC) Therapy, Product and Application
Table 23. Global Key Players of Mesenchymal Stem Cell (MSC) Therapy, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Mesenchymal Stem Cell (MSC) Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share by Type (2020-2025)
Table 27. Global Mesenchymal Stem Cell (MSC) Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share by Type (2026-2031)
Table 29. Global Mesenchymal Stem Cell (MSC) Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share by Application (2020-2025)
Table 31. Global Mesenchymal Stem Cell (MSC) Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share by Application (2026-2031)
Table 33. North America Mesenchymal Stem Cell (MSC) Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Mesenchymal Stem Cell (MSC) Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Mesenchymal Stem Cell (MSC) Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Mesenchymal Stem Cell (MSC) Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Mesenchymal Stem Cell (MSC) Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Mesenchymal Stem Cell (MSC) Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 48. TotiCell Company Details
Table 49. TotiCell Business Overview
Table 50. TotiCell Mesenchymal Stem Cell (MSC) Therapy Product
Table 51. TotiCell Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 52. TotiCell Recent Development
Table 53. Celltex Company Details
Table 54. Celltex Business Overview
Table 55. Celltex Mesenchymal Stem Cell (MSC) Therapy Product
Table 56. Celltex Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 57. Celltex Recent Development
Table 58. InGeneron Company Details
Table 59. InGeneron Business Overview
Table 60. InGeneron Mesenchymal Stem Cell (MSC) Therapy Product
Table 61. InGeneron Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 62. InGeneron Recent Development
Table 63. Stempeutics Bangalore Company Details
Table 64. Stempeutics Bangalore Business Overview
Table 65. Stempeutics Bangalore Mesenchymal Stem Cell (MSC) Therapy Product
Table 66. Stempeutics Bangalore Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 67. Stempeutics Bangalore Recent Development
Table 68. PuREC Company Details
Table 69. PuREC Business Overview
Table 70. PuREC Mesenchymal Stem Cell (MSC) Therapy Product
Table 71. PuREC Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 72. PuREC Recent Development
Table 73. Corestem Company Details
Table 74. Corestem Business Overview
Table 75. Corestem Mesenchymal Stem Cell (MSC) Therapy Product
Table 76. Corestem Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 77. Corestem Recent Development
Table 78. Sartorius Company Details
Table 79. Sartorius Business Overview
Table 80. Sartorius Mesenchymal Stem Cell (MSC) Therapy Product
Table 81. Sartorius Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 82. Sartorius Recent Development
Table 83. StemcellX Company Details
Table 84. StemcellX Business Overview
Table 85. StemcellX Mesenchymal Stem Cell (MSC) Therapy Product
Table 86. StemcellX Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 87. StemcellX Recent Development
Table 88. Cynata Company Details
Table 89. Cynata Business Overview
Table 90. Cynata Mesenchymal Stem Cell (MSC) Therapy Product
Table 91. Cynata Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 92. Cynata Recent Development
Table 93. Amniotic Company Details
Table 94. Amniotic Business Overview
Table 95. Amniotic Mesenchymal Stem Cell (MSC) Therapy Product
Table 96. Amniotic Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 97. Amniotic Recent Development
Table 98. Nuwacell Company Details
Table 99. Nuwacell Business Overview
Table 100. Nuwacell Mesenchymal Stem Cell (MSC) Therapy Product
Table 101. Nuwacell Revenue in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025) & (US$ Million)
Table 102. Nuwacell Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Mesenchymal Stem Cell (MSC) Therapy Picture
Figure 2. Global Mesenchymal Stem Cell (MSC) Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Mesenchymal Stem Cell (MSC) Therapy Market Share by Type: 2024 VS 2031
Figure 4. Intravenous (IV) Features
Figure 5. Intranasal (IN) Features
Figure 6. Intraarticular (IA) Features
Figure 7. Others Features
Figure 8. Global Mesenchymal Stem Cell (MSC) Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Mesenchymal Stem Cell (MSC) Therapy Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Research Institute Case Studies
Figure 13. Others Case Studies
Figure 14. Mesenchymal Stem Cell (MSC) Therapy Report Years Considered
Figure 15. Global Mesenchymal Stem Cell (MSC) Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Mesenchymal Stem Cell (MSC) Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Mesenchymal Stem Cell (MSC) Therapy Market Share by Region: 2024 VS 2031
Figure 18. Global Mesenchymal Stem Cell (MSC) Therapy Market Share by Players in 2024
Figure 19. Global Top Mesenchymal Stem Cell (MSC) Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesenchymal Stem Cell (MSC) Therapy as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Mesenchymal Stem Cell (MSC) Therapy Revenue in 2024
Figure 21. North America Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Mesenchymal Stem Cell (MSC) Therapy Market Share by Country (2020-2031)
Figure 23. United States Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Mesenchymal Stem Cell (MSC) Therapy Market Share by Country (2020-2031)
Figure 27. Germany Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Mesenchymal Stem Cell (MSC) Therapy Market Share by Region (2020-2031)
Figure 35. China Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Mesenchymal Stem Cell (MSC) Therapy Market Share by Country (2020-2031)
Figure 43. Mexico Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Market Share by Country (2020-2031)
Figure 47. Turkey Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Mesenchymal Stem Cell (MSC) Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. TotiCell Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 51. Celltex Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 52. InGeneron Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 53. Stempeutics Bangalore Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 54. PuREC Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 55. Corestem Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 56. Sartorius Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 57. StemcellX Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 58. Cynata Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 59. Amniotic Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 60. Nuwacell Revenue Growth Rate in Mesenchymal Stem Cell (MSC) Therapy Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232